New Branch Characteristic about the Polish Pharma Market

Jelenia Gora/Poland - The lifespan of the Europeans rises and with it the requirements on the pharmaceutical industry. This is related to the necessity of having an ailment free life also in the advanced ages. Particularly the accelerating spread of civilization diseases in the developed nations requires great innovations and offers enormous opportunities.

Also in Poland, the biggest country within the new EU member states, the parmaceutical sector is inferiored by drastic changes. Especially the growth potential of the market with a market value of 14.32 billion PLN in 2005 is not utilised yet.

This available industry sector characteristics is a compact report of the pharmaceutical sector in Poland subdivided into 2 chapters and 8 sections. It describes the origin of the pharmaceuticals, divides them into categories and characterises the different distribution channels. It presents key data and shows the most important developments on the market as well as the challenges. At the same time the Polish pharma market is ranked into the worldwide pharmaceutical market. Therewith it provides interested investors all facts to enable them to make an evaluation of the market opportunities and its indication of utilisation.

Poland Consulting Services is specialized in the creation of market analyses and data bases as well as market entry strategies towards Poland. PCS also realizes the establishment of companies, creates corporate design, websites and advertisement and carries out online surveys.
Contact Person:
Daniel Blotenkämper
Managing Director

Poland Consulting Services
ul. Jasna 1/1
PL 58-500 Jelenia Gora
Phone: 0048 (0)75 64 74 008
Phone in Germany: 0049 (0)30 868 701 333
Fax: 0048 (0)75 64 74 009
E-Mail: office@polandconsulting.com